Intervacc AB (publ) (STO:IVACC)
Sweden · Delayed Price · Currency is SEK 0.9790
+0.2400 (32.48%)
Mar 20, 2026, 5:29 PM CET
Intervacc AB Market Cap
Intervacc AB has a market cap or net worth of 333.66 million as of March 20, 2026. Its market cap has increased by 296.89% in one year.
Market Cap
333.66M
Enterprise Value
172.84M
Revenue
20.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.98
Market Cap Chart
Since April 7, 2017, Intervacc AB's market cap has increased from 85.80M to 333.66M, an increase of 288.90%. That is a compound annual growth rate of 16.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 251.86M | -20.02% |
| Dec 30, 2025 | 314.91M | 255.38% |
| Dec 30, 2024 | 88.61M | -81.52% |
| Dec 29, 2023 | 479.41M | -63.48% |
| Dec 30, 2022 | 1.31B | -50.81% |
| Dec 30, 2021 | 2.67B | 0.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corline Biomedical AB | 386.76M |
| Ascelia Pharma AB | 383.14M |
| Bio-Works Technologies AB | 319.15M |
| Lipum AB | 302.28M |
| Elicera Therapeutics AB | 257.24M |
| Mendus AB | 254.29M |
| Sprint Bioscience AB | 224.75M |
| Initiator Pharma | 210.83M |